The World Health Organization (WHO) has recently issued a warning regarding the circulation of counterfeit semaglutide medications in the market. Semaglutide, a vital ingredient in Novo Nordisk's popular diabetes drug Ozempic and weight-loss treatment Wegovy, is being replicated in fake products. Surge in Counterfeit Semaglutides
Since the beginning of 2022, there has been a spike in cases of illegal semaglutide products in countries such as Brazil, the UK, and the United States. Following multiple reports of altered medications, WHO has officially expressed apprehensions. Escalating Demand for Fake Drugs
Moreover, there has been a notable uptick in the demand for these fraudulent drugs, posing a significant threat to public health. Health Hazards
WHO has underscored the risks linked to counterfeit medicines, emphasizing the potential health dangers associated with consuming products containing inaccurate ingredients. These fake drugs may lead to serious health complications arising from unregulated blood sugar levels and weight control. It is imperative for individuals to exercise caution and obtain medications solely from reputable sources to mitigate these risks. This cautionary alert serves as a reminder for consumers to stay vigilant and prioritize their health and well-being. Remember, stay informed and stay safe.